We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Cancer Research UK and its partners have kicked off a clinical trial to determine the potential of repurposing a drug used to treat inflammation of the pancreas for the treatment of COVID-19.